During the past decade, Toyonaka Municipal Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toyonaka Municipal Hospital" #1 sponsor was "Haruhiko Fukuda" with 2 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Japan Clinical Cancer Research Organization" with 1 trials sponsored and "Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toyonaka Municipal Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Toyonaka Municipal Hospital" are "Gastric Neoplasm" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Toyonaka Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Toyonaka Municipal Hospital" are "Drug" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aprepitant / Fosaprepitant" (1 trials), "DS-8201a" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials), "Neoadjuvant chemotherapy(TS-1+CDDP) followed by gastrectomy" (1 trials) and "Physician's Choice" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toyonaka Municipal Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Toyonaka Municipal Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Toyonaka Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toyonaka Municipal Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".